Status:

COMPLETED

A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

Lead Sponsor:

Eli Lilly and Company

Conditions:

Healthy

Eligibility:

All Genders

18-70 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to compare the amount of tirzepatide that gets into the blood stream and how long it takes the body to get rid of it, when injected under the skin of the upper arm and thi...

Eligibility Criteria

Inclusion

  • Healthy males or females of nonchildbearing potential as determined by medical history, physical examination, and other screening procedures
  • Are between the body mass index (BMI) of 18.5 and 45.0 kilograms per meter squared (kg/m²), inclusive, at screening
  • Are agreeable to receiving study treatment by injections under the skin

Exclusion

  • Have known allergies to tirzepatide or related compounds
  • Have a personal or family history of medullary thyroid carcinoma or have multiple endocrine neoplasia syndrome type 2
  • Have a history or presence of pancreatitis (history of chronic pancreatitis or idiopathic acute pancreatitis), elevation in serum amylase or lipase or gastrointestinal (GI) disorder (eg, relevant esophageal reflux or gall bladder disease) or any GI disease which impacts gastric emptying (eg, gastric bypass surgery, pyloric stenosis, with the exception of appendectomy) or could be aggravated by glucagon-like peptide-1 (GLP-1) analogs or dipeptidyl peptidase IV (DPP-IV) inhibitors
  • Have a prior history of malignant disease(s) in the past 5 years prior to screening
  • Smoke more than the equivalent of 10 cigarettes per day
  • Is a known user of drugs of abuse

Key Trial Info

Start Date :

September 13 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 3 2020

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT04050670

Start Date

September 13 2019

End Date

April 3 2020

Last Update

May 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Covance Clinical Research Inc

Daytona Beach, Florida, United States, 32117